Androgenic alopeciahttps://en.wikipedia.org/wiki/Pattern_hair_loss
Androgenic alopecia bụ ntutu isi nke na-emetụta isi na ihu isi isi. N'ụdị ntutu isi nwoke (MPHL), ntutu isi na-egosipụtakarị onwe ya dị ka ntutu isi na-ala azụ, ntutu na-apụ na vertex nke isi isi, ma ọ bụ ngwakọta nke ha abụọ. Ụdị ntutu isi nke nwanyị (FPHL) na-egosipụtakarị dị ka mkparị ntutu n'ofe isi niile.

Ụdị ntutu isi nke nwoke yiri ka ọ bụ n'ihi njikọta nke mkpụrụ ndụ ihe nketa na androgens na-ekesa, karịsịa dihydrotestosterone (DHT). Ihe na-akpata ntutu isi ụmụ nwanyị ka edobeghị anya.

Ọgwụgwọ ndị a na-ahụkarị gụnyere minoxidil, finasteride, dutasteride, ma ọ bụ ịwa ahụ ntụgharị ntutu. Iji finasteride na dutasteride mee ihe n'ime ụmụ nwanyị dị ime nwere ike ịkpata nkwarụ ọmụmụ.

○ Ọgwụgwọ
Finasteride na dutasteride kacha dị irè maka ụmụ nwoke na ụmụ nwanyị postmenopausal. Enwere ike iji obere minoxydil ọnụ na-enye obere dose maka nhọrọ nhọrọ ole na ole.
#Finasteride
#Dutasteride

○ Ọgwụgwọ ― OTC Ọgwụ
N'ọtụtụ mba, a na-enweta nkwadebe minoxidil n'elu ụlọ ahịa. Enwere ụfọdụ mgbakwunye na-ekwu na ọ dị irè megide ntutu isi, mana ọtụtụ egosighi na sayensị na ọ dị irè.
#5% minoxidil
☆ Na nsonaazụ Stiftung Warentest nke 2022 sitere na Germany, afọ ojuju ndị ahịa na ModelDerm dị ntakịrị ntakịrị karịa na nyocha telemedicine akwụ ụgwọ.
  • Male-pattern hair loss
    References Treatment options for androgenetic alopecia: Efficacy, side effects, compliance, financial considerations, and ethics 34741573 
    NIH
    Although topical minoxidil, oral finasteride, and low‐level light therapy are the only FDA‐approved therapies to treat AGA, they are just a fraction of the treatment options available, including other oral and topical modalities, hormonal therapies, nutraceuticals, PRP and exosome treatments, and hair transplantation.